![]() |
產(chǎn)地 | 進(jìn)口、國產(chǎn) |
品牌 | 上海莼試 |
保存條件 | Store at -20 °C |
貨號(hào) | CS11407 |
應(yīng)用范圍 | WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500 |
CAS編號(hào) | |
抗體名 | Anti-Spinophilin/Neurabin 2 |
克隆性 | |
靶點(diǎn) | 詳見說明書 |
適應(yīng)物種 | 詳見說明書 |
形態(tài) | 詳見說明書 |
宿主 | 詳見說明書 |
亞型 | IgG |
標(biāo)識(shí)物 | 詳見說明書 |
濃度 | 1mg/1ml% |
免疫原 | KLH conjugated synthetic peptide derived from human Spinophilin/Neurabin 2 |
中文名稱 神經(jīng)組織特異性F肌動(dòng)蛋白結(jié)合蛋白2抗體品牌
英文名稱 Anti-Spinophilin/Neurabin 2
別 名 FLJ30345; NEB2_HUMAN; Neurabin II; Neurabin-2; Neurabin-II; Neurabin2; NeurabinII; Neurabin II; Neural tissue specific F actin binding protein II; p130; PP1bp134; PPP1R6; PPP1R9; PPP1R9B; Protein phosphatase 1 regulatory subunit 9B; SPINO; Spinophilin.
產(chǎn)品屬性:
神經(jīng)組織特異性F肌動(dòng)蛋白結(jié)合蛋白2抗體品牌 濃 度 1mg/1ml
規(guī) 格 0.2ml/200μg
抗體來源 Rabbit
克隆類型 polyclonal
交叉反應(yīng) Human, Mouse, Rat, Dog, Pig, Sheep
產(chǎn)品類型 一抗
研究領(lǐng)域 細(xì)胞生物 神經(jīng)生物學(xué) 信號(hào)轉(zhuǎn)導(dǎo) 細(xì)胞粘附分子 細(xì)胞骨架
蛋白分子量 predicted molecular weight: 89kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated synthetic peptide derived from human Spinophilin/Neurabin 2
亞 型 IgG
純化方法 affinity purified by Protein A
儲(chǔ) 存 液 Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4
神經(jīng)組織特異性F肌動(dòng)蛋白結(jié)合蛋白2抗體品牌 產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
(石蠟切片需做抗原修復(fù))
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
產(chǎn)品介紹 Neurabin-II, also called spinophilin, interacts with actin and PP-1 in dendritic spines of the central nervous system (1,2). The gene encoding human neurabin-II maps to chromosome 17q21-q22 (2). The structural characteristics of neurabin-II include one F-actin binding domain at the N-terminal region, a predicted coiled-coil struture at the C-terminal, one PDZ domain at the middle region, and a domain known to interact with transmembrane proteins (1). Neurabin-II bundles actin fliaments in vitro (1). In vivo, spinophilin localizes to the cortical sites of actin filaments and to the sites of active membrane remodelling (4). Neurabin-II also forms a complex with the catalytic subunit of PP1 and modulates PP1 enzymatic activity in vitro (2). Neurabin-II localizes to the head of dendritic spines (2) and aids in the ability of PP-1 to regulate the activity of a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) and N-methyl-D-asparate (NMDA) receptors (3). In this manner, neurabin-II modulates both glutamatergic synaptic transmission and dendritic morphology (3). Synergistic interactions between spinophilin and human tumor supressor ARF suggest a role for neurabin-II in cell growth (5).
Function : Seems to act as a scaffold protein in multiple signaling pathways. Modulates excitatory synaptic transmission and dendritic spine morphology. Binds to actin filaments (F-actin) and shows cross-linking activity. Binds along the sides of the F-actin. May play an important role in linking the actin cytoskeleton to the plasma membrane at the synaptic junction. Believed to target protein phosphatase 1/PP1 to dendritic spines, which are rich in F-actin, and regulates its specificity toward ion channels and other substrates, such as AMPA-type and NMDA-type glutamate receptors. Plays a role in regulation of G-protein coupled receptor signaling, including dopamine D2 receptors and alpha-adrenergic receptors. May establish a signaling complex for dopaminergic neurotransmission through D2 receptors by linking receptors downstream signaling molecules and the actin cytoskeleton. Binds to ADRA1B and RGS2 and mediates regulation of ADRA1B signaling. May confer to Rac signaling specificity by binding to both, RacGEFs and Rac effector proteins. Probably regulates p70 S6 kinase activity by forming a complex with TIAM1 (By similarity). Required for hepatocyte growth
Subunit : Interacts with DCLK2 (By similarity). Possibly exists as a homodimer, homotrimer or a homotetramer. Interacts with F-actin, PPP1CA, neurabin-1, TGN38 and D(2) dopamine receptor. Interacts with RGS1, RGS2, RGS4, RGS19 and ADRA1B, ADRA2A, ADRA2B, ADRA2C, CDKN2A, PPP1R2, RASGFR1 and TIAM1. Interacts (via C-terminus) with SPATA13 (via C-terminal tail).
Subcellular Location : Cytoplasm > cytoskeleton. Nucleus. Cell projection > dendritic spine. Cell junction > synapse. Cell junction > adherens junction. Cytoplasm. Cell membrane. Cell projection > lamellipodium. Cell projection > filopodium. Cell projection > ruffle membrane. Enriched at synapse and cadherin-based cell-cell adhesion sites. In neurons, both cytosolic and membrane-associated, and highly enriched in the post-synaptic density apposed to exitatory synapses. Colocalizes with PPP1R2 at actin-rich adherens junctions in epithelial cells and in dendritic spines (By similarity). Accumulates in the lamellipodium, filopodium and ruffle membrane in response to hepatocyte growth factor (HGF) treatment.
Post-translational modifications : Stimulation of D1 (but not D2) dopamine receptors induces Ser-94 phosphorylation. Dephosphorylation of Ser-94 is mediated mainly by PP1 and to a lesser extent by PP2A. Phosphorylation of spinophilin disrupts its association with F-actin, but does not affect its binding to PP1.
Similarity : Contains 1 PDZ (DHR) domain.
Database links : UniProtKB/Swiss-Prot: Q96SB3.2
實(shí)驗(yàn)流程:
全、新、優(yōu)、品、好四大特點(diǎn):
神經(jīng)組織特異性F肌動(dòng)蛋白結(jié)合蛋白2抗體品牌 全:公司提供上萬種產(chǎn)品,涵蓋了生物試劑,elisa試劑盒,標(biāo)準(zhǔn)品,培養(yǎng)基,原裝耗材,抗體、培養(yǎng)基、ATCC細(xì)胞等,基本上各種科研所需產(chǎn)品在我司都能找到。
新:產(chǎn)品更新速度較快,基本上每周都有新產(chǎn)品出現(xiàn)。
優(yōu):產(chǎn)品質(zhì)量好,投訴比較少。
好:我公司具有優(yōu)質(zhì)的技術(shù)團(tuán)隊(duì),產(chǎn)品一旦售出,實(shí)驗(yàn)過程中遇到困難可提供在線技術(shù)咨詢。使您使用產(chǎn)品時(shí)沒有任何的后顧之憂。
技術(shù)外包服務(wù):
★神經(jīng)組織特異性F肌動(dòng)蛋白結(jié)合蛋白2抗體品牌 分子生物學(xué):質(zhì)粒抽提、PCR、Q-PCR、RT-PCR、分子生物學(xué):基因合成、引物合成、基因測(cè)序、載體構(gòu)建等
★蛋白工程:原核、哺乳動(dòng)物蛋白表達(dá)系統(tǒng)等
★病毒包裝:腺病毒、慢病毒等
★抗體工程:磁珠分選、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等
★細(xì)胞工程:細(xì)胞表型分析(凋亡、增殖、周期、遷移、侵襲、修復(fù)、克隆形成)、細(xì)胞培養(yǎng)、細(xì)胞膜制備、穩(wěn)定細(xì)胞株構(gòu)建、細(xì)胞RNAi技術(shù)等等。
正在熱銷的相關(guān)產(chǎn)品:
Anti-Phospho-SGK1 (Thr256)/FITC 熒光素標(biāo)記磷酸化糖皮質(zhì)激素調(diào)節(jié)激酶1抗體IgGMulti-class antibodies規(guī)格: 0.2ml
ALK (Anaplastic Lymphoma Kinase)(CD246Ag) 間變型激酶(抗原)Multi-class antibodies規(guī)格: 0.5mg
核受體輔助抑制因子抗體 Anti-N-coR1 0.2ml
Phospho-5-Lipoxygenase(Ser663) 英文名稱: 磷酸化5-脂氧合酶抗體 0.1ml
eIF2 alpha 英文名稱: 真核啟動(dòng)因子2α抗體(eIFα2) 0.2ml
Rhesus antibody Rh phospho-PAK1+PAK2+PAK3 (Ser141) 磷酸化p21激活激酶1/2/3抗體 規(guī)格 0.1ml
ALK (Anaplastic Lymphoma Kinase)(CD246Ag) 間變型激酶(抗原)Multi-class antibodies規(guī)格: 0.5mg
Anti-TNF- Alpha /HRP 辣根過氧化物酶標(biāo)記壞死因子抗體IgGMulti-class antibodies規(guī)格: 0.2ml
PLGF (Placenta growth factor) 小鼠胎盤生長因子(多肽抗原)Multi-class antibodies規(guī)格: 0.5mg
膠質(zhì)細(xì)胞系源性神經(jīng)營養(yǎng)因子受體β抗體 Anti-TmR2 0.2ml
5HT1F Receptor 英文名稱: 5-羥色胺受體1F抗體 0.2ml
phospho-ERK1 (Thr197 +Thr202) 英文名稱: 磷酸化原活化蛋白激酶1/2抗體 0.1ml
Rhesus antibody Rh phospho-JunB(Ser259) 磷酸化活化蛋白激酶B抗體 規(guī)格 0.1ml
PLGF (Placenta growth factor) 小鼠胎盤生長因子(多肽抗原)Multi-class antibodies規(guī)格: 0.5mg
P(Raf kinase inhibitor protein) Raf激酶抑制蛋白抗原Multi-class antibodies規(guī)格: 0.5mg
Anti-Aurora C 有絲分裂激酶B抗體Multi-class antibodies規(guī)格: 0.2ml
Rhesus antibody Rh phospho-Akt(Thr450) 磷酸化蛋白激酶B抗體 規(guī)格 0.1ml
Melanoma 濃縮液 0.1ml 進(jìn)口分裝
UNC5B 英文名稱: 神經(jīng)突起誘導(dǎo)因子受體UNC5B抗體 0.1ml
CATSPER4 英文名稱: 陽離子通道相關(guān)蛋白4抗體 0.2ml
Anti-Aurora C 有絲分裂激酶B抗體Multi-class antibodies規(guī)格: 0.2ml
IL24 Protein Human 重組人 IL-24 / MDA-7 蛋白 (His 標(biāo)簽)
小鼠卵巢上皮細(xì)胞完全培養(yǎng)基 100mL
EGFR Others Mouse 小鼠 EGFR / HER1 / ErbB1 人細(xì)胞裂解液 (陽性對(duì)照)
F98大鼠腦細(xì)胞 F98 rat glioma cells DMEM+10%FBS
T-112A胰凝乳蛋白酶(含10mL酶解緩沖液)1mL
Sp2/0-Ag14(小鼠細(xì)胞) 5×106cells/瓶×2 C6(腦細(xì)胞)
CM-M047小鼠腸微細(xì)胞完全培養(yǎng)基100mL
TACSTD2 Others Mouse 小鼠 OP2 / TACSTD2 人細(xì)胞裂解液 (陽性對(duì)照)
小鼠腎小管上皮細(xì)胞完全培養(yǎng)基 100mL
S-180小鼠腹水瘤細(xì)胞 Mouse S-180 ascites tumor cells RPMI-1640(GIBCO)+10%FBS
IL12B Protein Rat 重組大鼠 IL12B / IL-12B 蛋白 (His 標(biāo)簽)
TE-11(人細(xì)胞) 5×106cells/瓶×2 A-704(人細(xì)胞)
神經(jīng)組織特異性F肌動(dòng)蛋白結(jié)合蛋白2抗體品牌 IL24 Protein Human 重組人 IL-24 / MDA-7 蛋白 (His 標(biāo)簽)
小鼠卵巢上皮細(xì)胞完全培養(yǎng)基 100mL
EGFR Others Mouse 小鼠 EGFR / HER1 / ErbB1 人細(xì)胞裂解液 (陽性對(duì)照)
F98大鼠腦細(xì)胞 F98 rat glioma cells DMEM+10%FBS
T-112A胰凝乳蛋白酶(含10mL酶解緩沖液)1mL
Sp2/0-Ag14(小鼠細(xì)胞) 5×106cells/瓶×2 C6(腦細(xì)胞)